戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 o those of parent lead structures (i.e., the hypolipidemic 2-hydroxy-2-aryl-(benzo)oxa(or thia)zine a
2 wever, when GLP-1 activity is sustained, the hypolipidemic action of GLP-1 predominates.
3 rogenic index of plasma (AIP) suggesting its hypolipidemic action.
4 dation via PERPP, and may be relevant to the hypolipidemic actions of dietary PUFAs, the basal regula
5 tory, and squalene synthase (SQS) inhibitory/hypolipidemic activities are combined in simple molecule
6  exhibited substantial antihyperglycemic and hypolipidemic activities when orally administered in thr
7 digestion resistant maltodextrin exert their hypolipidemic activity by different mechanisms.
8 glycemic efficacy in a db/db mouse model and hypolipidemic activity in hamster and dog models without
9  is likely that this effect accounts for the hypolipidemic activity of these phytosteroids.
10 acid extracted SDF of quince showed in vitro hypolipidemic activity, with cholesterol adsorption capa
11  lower cholesterol which has been found as a hypolipidemic agent in commercial red yeast rice.
12             We investigated the effects of a hypolipidemic agent, nordihydroguaiaretic acid (NDGA), o
13 se have the potential to be a novel class of hypolipidemic agent, which possess combined hypocholeste
14 ses that are highly inducible by fibric acid hypolipidemic agents and other peroxisome proliferators.
15 scular risk independent of changes in use of hypolipidemic agents, smoking, blood pressure, BMI, or l
16 mprove the safety and effectiveness of these hypolipidemic agents.
17 site manners by ritonavir and bezafibrate, a hypolipidemic agonist of the peroxisome proliferator-act
18 nthesis of a trifluoromethylated analog of a hypolipidemic and anti-obesity agent.
19 or-mediated actions pertain to their role in hypolipidemic and antidiabetic therapies and as potentia
20                                              Hypolipidemic and antihyperlipidemic effect from an aque
21   Evidently the extract possesses pronounced hypolipidemic and antihyperlipidemic effects which are c
22 hese compounds as a new class of dual-acting hypolipidemic and antiobesity agents.
23                                              Hypolipidemic and antiobesity effects of the newly synth
24                                          The hypolipidemic and antioxidant actions of thymoquinone (T
25                      Gnasxl(m+/p-) mice were hypolipidemic and had increased glucose tolerance and in
26                 Gemfibrozil is a widely used hypolipidemic and triglyceride lowering drug.
27 -inflammatory, immunomodulatory, anticancer, hypolipidemic, and antithrombotic potential.
28 cardioprotective, anti-hypercholesterolemic, hypolipidemic, anti-atherosclerosis, anti-obesity agains
29 iated with numerous health benefits, such as hypolipidemic, anti-inflammatory, anti-hypertensive, ant
30 ties compared to flavonoid monomers, such as hypolipidemic, antidiabetic, and neuroprotective activit
31 st has focused on various herbs that possess hypolipidemic, antiplatelet, antitumor, or immune-stimul
32                                        These hypolipidemic apoE2 transgenic mice were cross-bred with
33 , without modifying the diet or initiating a hypolipidemic drug, by the transient induction of Cre ex
34 inflammatory drugs and a commonly prescribed hypolipidemic drug.
35 s the primary target of the fibrate class of hypolipidemic drugs and mediates lipid lowering in part
36 ferators are of exogenous origin and include hypolipidemic drugs and other industrial chemicals, seve
37 c reticulum (ER) proteins, inducible by many hypolipidemic drugs and peroxisome proliferators.
38 how here that specific FAs, eicosanoids, and hypolipidemic drugs are ligands for PPARalpha or PPARdel
39 vated by diverse environmental chemicals and hypolipidemic drugs classified as peroxisome proliferato
40 eptor-alpha (PPARalpha), the target for most hypolipidemic drugs in current clinical use, regulates t
41 unds including fatty acids, eicosanoids, and hypolipidemic drugs such as fibrates and thiazolidinedio
42 uctase inhibitors) are an important group of hypolipidemic drugs that are able to modulate inflammati
43 a nuclear receptor activated by fatty acids, hypolipidemic drugs, and peroxisome proliferators (PPs).
44 activators, such as the fibric acid class of hypolipidemic drugs, and PPAR-gamma agonists, including
45        Since PPARalpha activators, which are hypolipidemic drugs, are being prescribed for a signific
46  (PPARalpha) mediates the effects of several hypolipidemic drugs, endogenous fatty acids, and peroxis
47                  Numerous compounds, such as hypolipidemic drugs, herbicides, plasticizers, and analg
48 o monitor the effect of statins, a family of hypolipidemic drugs, on synthetic lipid membranes.
49                                              Hypolipidemic drugs, such as bezafibrate, known activato
50  of beta-oxidation and a prominent target of hypolipidemic drugs.
51    Experiments in humans indicate a profound hypolipidemic effect of fish oil, especially lowering of
52 ult to uncover the biochemical basis for the hypolipidemic effect of fish oils in humans through use
53  that procyanidin A may impart a key role of hypolipidemic effect seen in peanut skin polyphenols.
54                              It had a potent hypolipidemic effect.
55              Recently, PDX was found to have hypolipidemic effects and effects on the gut microbiota.
56 s was conducted to more precisely define the hypolipidemic effects and safety of psyllium when used a
57 ryptophan metabolism are associated with the hypolipidemic effects observed in mice that were given P
58 AR gamma also abolished the hypoglycemic and hypolipidemic effects of rosiglitazone, demonstrating th
59                                          The hypolipidemic effects of the fibrate drugs and the antid
60 hing a plausible mechanism of action for the hypolipidemic effects of these extracts.
61 ry roles in determining the antidiabetic and hypolipidemic effects of thiazolidinediones.
62 G-rich oil is a low calorie fat and exhibits hypolipidemic effects.
63 ceptor alpha (PPARalpha) agonist with strong hypolipidemic effects.
64 is recognized as the molecular target of the hypolipidemic fibrate drugs.
65 a from the 1994 PDR for all drugs listed as "hypolipidemics." For comparison, we selected a stratifie
66 n on fat excretion in order to elucidate its hypolipidemic mechanism.
67 all persons who are currently candidates for hypolipidemic medication because they are at high risk f
68 BMI), blood pressure, smoking status, use of hypolipidemic medications, and fasting lipids were deter
69                           In contrast to the hypolipidemic mice, mice expressing high levels of apoE2
70 oE2 in the transgenic mice leads to either a hypolipidemic or hyperlipidemic phenotype.
71            Fifth, the CoA thioesters of some hypolipidemic peroxisome proliferators bind with high af
72 dely popular because of its hypoglycemic and hypolipidemic properties but various cases of T. polium-
73 of peanut skin (PE) was investigated for its hypolipidemic properties in rats on Western diet.
74  of chitin, is a dietary fibre known for its hypolipidemic properties, which are mainly attributed to
75  including procyanidins and is shown to have hypolipidemic properties.
76 ancer, antithrombotic, immunomodulatory, and hypolipidemic properties.
77                             Results show the hypolipidemic property of FVW-FO and reduced HMG-CoA red
78                                              Hypolipidemic statin drugs, particularly rosuvastatin (R
79 tablished that PPARs are the targets for the hypolipidemic synthetic compounds known as peroxisome pr
80 ould be confounded by pleiotropic effects of hypolipidemic treatment.